Non-Surgical Approach to Managing Hip Osteoarthritis in Perth Amboy
Are You a Regenexx Candidate?Can Hip Pain from Osteoarthritis Be Addressed Without Surgery?
Non-surgical approaches for managing hip discomfort related to osteoarthritis are available through physicians in the licensed Regenexx network.
Discomfort is one of the most common symptoms associated with hip osteoarthritis, often occurring more frequently than joint stiffness or mobility limitations. If a physician has indicated that hip pain is caused by osteoarthritis and suggested that joint replacement is the only path forward, exploring less invasive alternatives may be beneficial.
Hip osteoarthritis develops as the cartilage surfaces within the joint gradually deteriorate. Interventional orthobiologic procedures using Regenexx injectates may help support the body’s natural ability to reduce discomfort and may help improve joint function. These less invasive approaches may offer shorter recovery times and may carry fewer potential complications when compared to typical surgical interventions.
Patients seeking consultation for hip osteoarthritis in the New Jersey area may visit Pain Doctors Medical at 345 State Perth Amboy, NJ, a location in the licensed Regenexx network.
| Regenexx-SD | Surgery | |
|---|---|---|
| Return to Daily Routine | 2 to 5 days | 6+ weeks |
| Return to Sports | 3 to 6 months | 1 year |
| Recovery | Brace, up to 6 weeks PT | Crutches, brace, extensive, no driving, 3 to 6 months PT |
| Pain Management | Mostly over-the-counter pain medication (days) | Prescription pain medication for weeks (weeks) |
| General Anesthesia | No | Yes |
| Keep Your Hip Joint | Yes | No |
345 State Street
Perth Amboy, NJ 08861
Request an Appointment
Call to Schedule Schedule OnlineClinic Hours
| Sunday | Closed |
| Monday | 9AM–5PM |
| Tuesday | 9AM–5PM |
| Wednesday | 9AM–5PM |
| Thursday | 9AM–5PM |
| Friday | 9AM–5PM |
| Saturday | Closed |
How Does the Regenexx Approach Work?
The Regenexx approach at Pain Doctors Medical in Perth Amboy, New Jersey, is a form of interventional orthobiologics that offers an alternative to typical orthopedic surgery. Procedures using Regenexx SD injectate are performed by physicians in the licensed Regenexx network and use advanced image guidance to precisely place a patient’s own bone marrow concentrate, containing cells that may support the body’s natural healing response, into areas of the hip joint where tissue damage has been identified [2-3].
The healing agents in the bone marrow concentrate may help support the repair process by promoting the growth of new tissue. This may aid in stabilizing the hip joint and may help improve function and mobility over time[4].
What Are the Risks of Hip Replacement Surgery and Other Treatments?
Hip replacement and hip resurfacing are considered invasive procedures that often involve extended recovery periods. This may include physical therapy and ongoing discomfort as the joint regains strength and mobility.
Potential risks linked to these surgical interventions include:
- Anesthesia-related complications, such as stroke or heart attack.
- Infection and blood clots.
- Prosthetic part failure, pseudotumors, and allergic reactions to metal components.
Furthermore, joint replacements may not be permanent and could necessitate revision procedures over time[5-6]. While many patients choose surgery hoping to return to an active lifestyle, a 2016 meta-analysis of 17 clinical trials found no statistically significant improvement in physical activity levels for up to one year following a unilateral primary total hip replacement.
Pain management strategies also carry potential risks. Nonsteroidal anti-inflammatory drugs (NSAIDs) have been associated with an increased risk of cardiovascular events, while opioid use carries a high potential for dependence. Additionally, steroid injections may lead to undesirable side effects[7-10].
For those looking to avoid the potential risks associated with typical surgical treatments or long-term medication use, physicians in the licensed Regenexx network offer alternative procedures. These interventional orthobiologic procedures using Regenexx injectates are designed to support the body’s natural healing mechanisms without the need for invasive surgery.
The Regenexx Approach for Hip Pain
Physicians in the licensed Regenexx network take a comprehensive and customized approach to evaluating hip discomfort. During an initial visit, the physician may assess joint function in motion and use diagnostic ultrasound to view the structures of the hip in real time. This process helps identify the underlying factors contributing to discomfort and limitations in mobility.
Following this thorough evaluation, the physician develops a customized treatment plan specific to the patient’s condition and needs. Depending on the findings, the plan may utilize one or more of the following Regenexx injectates:
- Regenexx SD Injectate: Prepared using proprietary treatment protocols involving Bone Marrow Concentrate (BMC), which contains the patient’s own mesenchymal signaling cells and other cellular healing agents.
- Regenexx SCP Injectate: A proprietary, lab-processed formulation of Platelet-Rich Plasma (PRP) that contains a higher concentration of growth factors compared to typical PRP preparations.
- Regenexx PL Injectate: A specialized derivative of PRP known as platelet lysate (PL), which is designed for a faster and more targeted release of growth factors.
These procedures utilize proprietary Regenexx processing methods and interventional orthobiologics . They are intended to may support the body’s natural healing mechanisms, offering a non-surgical alternative for addressing hip discomfort.
Patients interested in a thorough evaluation of their hip condition may consult with a physician at Pain Doctors Medical at 345 State Perth Amboy, NJ, a location in the licensed Regenexx network.
Webinar: Addressing Hip Pain from Osteoarthritis Without Surgery
Join Chris Centeno, M.D., founder of Regenexx, for a free educational webinar exploring how procedures using Regenexx lab processes may offer a non-surgical option for managing hip pain caused by osteoarthritis.
In this webinar, patients will learn:
- How procedures using bone marrow concentrate and platelet-rich plasma (PRP) may compare to typical surgical options and other interventions
- What to expect during and after procedures using Regenexx injectates
- Answers to frequently asked questions about interventional orthobiologics and Regenexx’s proprietary methods
FAQs
Osteoarthritis of the hip is characterized by fast-progressing degeneration of hip tissue that causes impairment of function. Arthritis may result from inflammatory disorders, genetic predisposition, infections, hip injuries, or simple wear and tear.
Hip arthritis usually occurs in people in their 60s and 70s, but onset can vary depending on activity level, body weight, and the structure of your hip joint.
No. In some people, especially in the early stages, hip arthritis presents as joint stiffness or limited range of motion. Over time, however, as the degeneration in the joint worsens, it usually becomes painful.
Yes, most degenerative changes in the hip can be identified with an MRI. In the following video Chris Centeno, MD, identifies the top three arthritis changes to look for on a hip MRI.
At first glance, a hip resurfacing sounds less invasive, which most people assume translates to fewer complications. But that’s not necessarily true. During a conventional hip replacement surgery, the entire ball and socket of the hip joint are replaced with artificial implants made of either metal or ceramic or a combination of the two. The stemmed component of the implant is placed in the marrow cavity of the femur (thighbone).
In hip resurfacing, the ball on the top of the femur is not removed — it’s shaved so that a metal ball can be placed around it. With this procedure, the thighbone is preserved, so it’s considered less invasive. However, research illustrates the downsides of this procedure are increased chance of thigh fracture, larger incision and scar, pseudotumors, earlier failure of the prosthesis, and metal-only prosthetic materials that can shed particles into the bloodstream.11-12
Get started to see if you are a Regenexx candidate
To talk one-on-one with one of our team members about how the Regenexx approach may be able to help your orthopedic pain or injury, please complete the form below and we will be in touch with you within the next business day.
References
- Trouvin AP, Perrot S. Pain in osteoarthritis. Implications for optimal management. Joint Bone Spine. 2018 Jul;85(4):429-434. doi: 10.1016/j.jbspin.2017.08.002. Epub 2017 Sep 6. PMID: 28889010. Sep 6. PMID: 28889010.
- Centeno CJ. Efficacy and Safety of Bone Marrow Concentrate for Osteoarthritis of the Hip; Treatment Registry Results for 196 Patients. J Stem Cell Res Ther 2014;04(10). doi:10.4172/2157-7633.1000242.
- Friedlis MF, Centeno CJ. Performing a Better Bone Marrow Aspiration. Phys Med Rehabil Clin N Am. 2016 Nov;27(4):919-939. doi: 10.1016/j.pmr.2016.06.009. PMID: 27788908.
- Centeno CJ, Kisiday J, Freeman M, Schultz JR. Partial regeneration of the human hip via autologous bone marrow nucleated cell transfer: A case study. Pain Physician. 2006 Jul;9(3):253-6.
- Lalmohamed A, Vestergaard P, Cooper C, de Boer A, Leufkens HG, van Staa TP, de Vries F. Timing of stroke in patients undergoing total hip replacement and matched controls: a nationwide cohort study. Stroke. 2012 Dec;43(12):3225-9. doi: 10.1161/STROKEAHA.112.668509. Epub 2012 Nov 6. PMID: 23132782.
- Harding P, Holland AE, Delany C, Hinman RS. Do activity levels increase after total hip and knee arthroplasty? Clin Orthop Relat Res. 2014 May;472(5):1502-11. doi: 10.1007/s11999-013-3427-3. Epub 2013 Dec 19. PMID: 24353051; PMCID: PMC3971219.
- How long does a hip replacement last? A systematic review and meta-analysis of case series and national registry reports with more than 15 years of follow-up Evans JT, Evans JP, Walker RW, Blom AW, Whitehouse MR, Sayers A. How long does a hip replacement last? A systematic review and meta-analysis of case series and national registry reports with more than 15 years of follow-up. Lancet. 2019;393(10172):647-654. doi:10.1016/S0140-6736(18)31665-9
- Withers TM, Lister S, Sackley C, Clark A, Smith TO. Is there a difference in physical activity levels in patients before and up to one year after unilateral total hip replacement? A systematic review and meta-analysis. Clin Rehabil. 2017;31(5):639-650. doi:10.1177/0269215516673884
- Sakaguchi M, Tanaka T, Fukushima W, Kubo T, Hirota Y; Idiopathic ONF Multicenter Case-Control Study Group. Impact of oral corticosteroid use for idiopathic osteonecrosis of the femoral head: a nationwide multicenter case-control study in Japan. J Orthop Sci. 2010;15(2):185-191. doi:10.1007/s00776-009-1439-3
- Ravi B, Escott BG, Wasserstein D, et al. Intraarticular hip injection and early revision surgery following total hip arthroplasty: a retrospective cohort study. Arthritis Rheumatol. 2015;67(1):162-168. doi:10.1002/art.38886
- Hjorth MH, Mechlenburg I, Soballe K, et al. Higher prevalence of mixed or solid pseudotumors in metal-on-polyethylene total hip arthroplasty compared with metal-on-metal total hip arthroplasty and resurfacing hip arthroplasty. J Arthroplasty, 2018;33:2279–2286. doi:10.1016/j.arth.2018.02.011.
- Oxblom A, Hedlund H, Nemes S, et al. Patient-reported outcomes in hip resurfacing versus conventional total hip arthroplasty: a register-based matched cohort study of 726 patients. Acta Orthop. 2019;90:318-323. doi:10.1080/17453674.2019.1604343.
